BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 22473208)

  • 1. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.
    Riley KJ; Rabinowitz GS; Yario TA; Luna JM; Darnell RB; Steitz JA
    EMBO J; 2012 May; 31(9):2207-21. PubMed ID: 22473208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ; Choi H; Kim H; Lee SK
    J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
    Feederle R; Linnstaedt SD; Bannert H; Lips H; Bencun M; Cullen BR; Delecluse HJ
    PLoS Pathog; 2011 Feb; 7(2):e1001294. PubMed ID: 21379335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.
    Amoroso R; Fitzsimmons L; Thomas WA; Kelly GL; Rowe M; Bell AI
    J Virol; 2011 Jan; 85(2):996-1010. PubMed ID: 21068248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
    Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation.
    Chen Y; Fachko D; Ivanov NS; Skinner CM; Skalsky RL
    PLoS Pathog; 2019 Jan; 15(1):e1007535. PubMed ID: 30615681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The viral and cellular microRNA targetome in lymphoblastoid cell lines.
    Skalsky RL; Corcoran DL; Gottwein E; Frank CL; Kang D; Hafner M; Nusbaum JD; Feederle R; Delecluse HJ; Luftig MA; Tuschl T; Ohler U; Cullen BR
    PLoS Pathog; 2012 Jan; 8(1):e1002484. PubMed ID: 22291592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.
    Qiu J; Cosmopoulos K; Pegtel M; Hopmans E; Murray P; Middeldorp J; Shapiro M; Thorley-Lawson DA
    PLoS Pathog; 2011 Aug; 7(8):e1002193. PubMed ID: 21901094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.
    Seto E; Moosmann A; Grömminger S; Walz N; Grundhoff A; Hammerschmidt W
    PLoS Pathog; 2010 Aug; 6(8):e1001063. PubMed ID: 20808852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
    Kang D; Skalsky RL; Cullen BR
    PLoS Pathog; 2015 Jun; 11(6):e1004979. PubMed ID: 26070070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes.
    Feederle R; Haar J; Bernhardt K; Linnstaedt SD; Bannert H; Lips H; Cullen BR; Delecluse HJ
    J Virol; 2011 Oct; 85(19):9801-10. PubMed ID: 21752900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition.
    Chen Y; Fachko DN; Ivanov NS; Skalsky RL
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
    Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
    BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary conservation of primate lymphocryptovirus microRNA targets.
    Skalsky RL; Kang D; Linnstaedt SD; Cullen BR
    J Virol; 2014 Feb; 88(3):1617-35. PubMed ID: 24257599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
    Homa NJ; Salinas R; Forte E; Robinson TJ; Garcia-Blanco MA; Luftig MA
    J Virol; 2013 Nov; 87(22):12291-301. PubMed ID: 24027308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
    Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
    Front Immunol; 2020; 11():367. PubMed ID: 32194570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus growth/latency III program alters cellular microRNA expression.
    Cameron JE; Fewell C; Yin Q; McBride J; Wang X; Lin Z; Flemington EK
    Virology; 2008 Dec; 382(2):257-66. PubMed ID: 18950829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
    Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
    RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.
    Mansouri S; Pan Q; Blencowe BJ; Claycomb JM; Frappier L
    J Virol; 2014 Oct; 88(19):11166-77. PubMed ID: 25031339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.